MGX (Metagenomi) FCF Yield % : -196.14 (As of Mar. 28, 2025)

View and export this data going back to 2024. Start your Free Trial

What is Metagenomi FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Metagenomi's Trailing 12-Month Free Cash Flow is $-112.19 Mil, and Market Cap is $57.20 Mil. Therefore, Metagenomi's FCF Yield % for today is -196.14%.

The historical rank and industry rank for Metagenomi's FCF Yield % or its related term are showing as below:

MGX' s FCF Yield % Range Over the Past 10 Years
Min: -196.14 Med: -96.79 Max: -22.11
Current: -196.14

During the past 4 years, the highest FCF Yield % of Metagenomi was -22.11%. The lowest was -196.14%. And the median was -96.79%.

MGX's FCF Yield % is ranked worse than
91.13% of 1500 companies
in the Biotechnology industry
Industry Median: -14.52 vs MGX: -196.14

Metagenomi's FCF Margin % for the quarter that ended in Dec. 2024 was -276.78%.

Metagenomi FCF Yield % Historical Data

The historical data trend for Metagenomi's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Metagenomi FCF Yield % Chart

Metagenomi Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

FCF Yield %

-83.05

Metagenomi Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Yield %	Get a 7-Day Free Trial							-	-31.13	-70.60	-137.08	-78.80

Competitive Comparison of Metagenomi's FCF Yield %

For the Biotechnology subindustry, Metagenomi's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Metagenomi's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Metagenomi's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Metagenomi's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Metagenomi FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Metagenomi's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-112.187	/	135.07898
	=	-83.05%

Metagenomi's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-26.61	*	4	/	135.07898
	=	-78.80%

Metagenomi FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Metagenomi FCF Yield % Related Terms

Thank you for viewing the detailed overview of Metagenomi's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Metagenomi Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Metagenomi Inc (NAS:MGX) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

5959 Horton Street, Emeryville, CA, USA, 94608

Website

https://www.metagenomi.co

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).